S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NYSEARCA:VTHRVanguard Russell 3000 ETF Stock Price, Forecast & News

$151.87
+0.15 (+0.10 %)
(As of 08/7/2020 04:00 PM ET)
Add
Today's Range
$150.90
Now: $151.87
$152.01
50-Day Range
$135.75
MA: $143.66
$151.67
52-Week Range
$97.77
Now: $151.87
$154.30
Volume50,801 shs
Average Volume27,395 shs
Market Capitalization$637.85 million
P/E RatioN/A
Dividend Yield1.62%
BetaN/A

Geographic Exposure of VTHR

Currency Exposure of VTHR

Sector Exposure of VTHR

Industry Exposure of VTHR


Basic Details

Issuer Vanguard
Fund NameVanguard Russell 3000 ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:VTHR
Inception Date9/20/2010
Fund ManagerMichael A. Johnson, Walter Nejman
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkRussell 3000 Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$634.12 million
Average Daily Volume$15,199.30
Discount/Premium0.11%

ETF Expenses

Management Fee0.12%
Other Expenses0.03%
Total Expenses0.15%
Fee Waiver0.00%
Net Expenses0.15%

Administrator, Advisor and Custodian

AdministratorThe Vanguard Group, Inc.
AdvisorThe Vanguard Group, Inc.
CustodianState Street Bank and Trust Company
DistributorVanguard Marketing Corporation
Transfer AgentThe Vanguard Group, Inc.
Trustee
Lead Market MakerVirtu Financial
$151.87
+0.15 (+0.10 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for VTHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vanguard Russell 3000 ETF (NYSEARCA:VTHR) Frequently Asked Questions

How has Vanguard Russell 3000 ETF's stock been impacted by COVID-19 (Coronavirus)?

Vanguard Russell 3000 ETF's stock was trading at $123.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VTHR shares have increased by 23.0% and is now trading at $151.87.
View which stocks have been most impacted by Coronavirus
.

Has Vanguard Russell 3000 ETF been receiving favorable news coverage?

News headlines about VTHR stock have trended somewhat negative on Friday, InfoTrie reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Vanguard Russell 3000 ETF earned a media sentiment score of -1.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Vanguard Russell 3000 ETF
.

What other stocks do shareholders of Vanguard Russell 3000 ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard Russell 3000 ETF investors own include Mastercard (MA), Invesco Dynamic Large Cap Growth ETF (PWB), iShares S&P 500 Growth ETF (IVW), Lam Research (LRCX), AON (AON), ANSYS (ANSS), Autodesk (ADSK), Adobe (ADBE), Copart (CPRT) and Johnson & Johnson (JNJ).

What is Vanguard Russell 3000 ETF's stock symbol?

Vanguard Russell 3000 ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "VTHR."

How do I buy shares of Vanguard Russell 3000 ETF?

Shares of VTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vanguard Russell 3000 ETF's stock price today?

One share of VTHR stock can currently be purchased for approximately $151.87.

How big of a company is Vanguard Russell 3000 ETF?

Vanguard Russell 3000 ETF has a market capitalization of $637.85 million.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.